亚洲欧美日韩成人痉挛重口_特黄三级视频不卡高清在线看_黄色欧美久久_国产成人在线观看99_日韓精品歐美國產精品亞_亚洲?V日韩?V国内怡红院_在线一级无码导航_黄色免费网站链接_中文字幕与邻居少妇性刺激_亚洲国产午夜福利网
<ul id="iuoqy"><tfoot id="iuoqy"></tfoot></ul>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2024.08.30
海普瑞：2024年半年度報告摘要
2024.07.12
海普瑞：2024年半年度業(yè)績預告
2024.04.30
海普瑞：關于續(xù)聘會計師事務所的公告
2024.04.30
海普瑞：關于2023年年度股東大會增加臨時提案暨股東大會補充通知的公告
2024.04.30
海普瑞：董事會決議公告
2024.04.30
海普瑞：關于舉行2023年年度業(yè)績說明會的公告
2024.04.02
海普瑞：關于依諾肝素鈉制劑獲得泰國藥品注冊批件的公告
2024.03.29
海普瑞：未來三年（2024年-2026年）股東回報規(guī)劃
2024.03.29
海普瑞：商譽減值測試報告
2024.03.29
海普瑞：關于依諾肝素鈉制劑獲得新西蘭藥品注冊批件的公告
第一頁
上一頁
1
2
3
4
5
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
